RT @LashMD: @YaseenarabiYa https://t.co/RtsETxDAqN @snamendys
@YaseenarabiYa https://t.co/RtsETxDAqN @snamendys
Namendys-Silva, et al. Outcome of critically ill patients with hematological malignancies. Ann Hematol 2013 http://t.co/svIlfWB823
Ñamendys-Silva et al: Outcome of critically ill patients with hematological malignancies. Ann Hematol 2013;92:699-705 http://t.co/K2m8FzIoyq
Ñamendys-Silva et al: Outcome of critically ill patients with hematological malignancies. Ann Hematol 2013;92:699-705 http://t.co/jzXTunAkwT
Ñamendys-Silva et al: Outcome of critically ill patients with hematological malignancies. Ann Hematol 2013;92:699-705 http://t.co/jzXTunAkwT
Ñamendys-Silva SA, et al. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013 Jan 18 http://t.co/SLXXZRro
Ñamendys-Silva SA, et al. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013 Jan 18 http://t.co/SLXXZRro
Ñamendys-Silva SA, et al. Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013 Jan 18 http://t.co/SLXXZRro
Ñamendys-Silva et al, Outcome of critically ill patients with hematological malignancies. Ann Hematol. 2013 Jan 18 http://t.co/SLXXZRro